<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2680787-A1" country="EP" doc-number="2680787" kind="A1" date="20140108" family-id="46757294" file-reference-id="312918" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146586874" ucid="EP-2680787-A1"><document-id><country>EP</country><doc-number>2680787</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12752846-A" is-representative="NO"><document-id mxw-id="PAPP154849066" load-source="docdb" format="epo"><country>EP</country><doc-number>12752846</doc-number><kind>A</kind><date>20120228</date><lang>EN</lang></document-id><document-id mxw-id="PAPP182063489" load-source="docdb" format="original"><country>EP</country><doc-number>12752846.1</doc-number><date>20120228</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140555997" ucid="AU-2011900679-A" load-source="docdb"><document-id format="epo"><country>AU</country><doc-number>2011900679</doc-number><kind>A</kind><date>20110228</date></document-id></priority-claim><priority-claim mxw-id="PPC140548420" ucid="AU-2012000199-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>AU</country><doc-number>2012000199</doc-number><kind>W</kind><date>20120228</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL2100271961" load-source="docdb">A61F   2/48        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100274670" load-source="docdb">A61L  31/06        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100275078" load-source="docdb">A61B   5/00        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100276144" load-source="docdb">A61F   2/30        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100276763" load-source="docdb">A61L  31/16        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100277717" load-source="docdb">A61F  13/00        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100277725" load-source="docdb">A61F   2/28        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100278083" load-source="docdb">A61F  13/12        20060101ALI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100279436" load-source="docdb">A61F   2/02        20060101AFI20140709BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL2100280262" load-source="docdb">A61F   2/00        20060101ALI20140709BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1763883983" load-source="docdb" scheme="CPC">A61L2300/41        20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883984" load-source="docdb" scheme="CPC">A61L2300/404       20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883985" load-source="docdb" scheme="CPC">A61L  31/16        20130101 LI20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883986" load-source="docdb" scheme="CPC">A61L  31/06        20130101 LI20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883987" load-source="docdb" scheme="CPC">A61F2002/485       20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883988" load-source="docdb" scheme="CPC">A61F2002/3096      20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883989" load-source="docdb" scheme="CPC">A61F2002/30932     20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883990" load-source="docdb" scheme="CPC">A61F2002/30677     20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883991" load-source="docdb" scheme="CPC">A61F2002/30672     20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883992" load-source="docdb" scheme="CPC">A61F2002/3067      20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883993" load-source="docdb" scheme="CPC">A61F2002/30069     20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883994" load-source="docdb" scheme="CPC">A61F  13/12        20130101 LI20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1763883995" load-source="docdb" scheme="CPC">A61B   5/686       20130101 LA20170922BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1934605385" load-source="docdb" scheme="CPC">A61F2002/009       20130101 LA20160601BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1934606210" load-source="docdb" scheme="CPC">A61F   2/0077      20130101 LI20160601BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2145967827" load-source="docdb" scheme="CPC">A61F   2/2875      20130101 FI20141017BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132365255" lang="DE" load-source="patent-office">CHIRURGISCHES IMPLANTAT UND VERFAHREN DAFÜR</invention-title><invention-title mxw-id="PT132365256" lang="EN" load-source="patent-office">SURGICAL IMPLANT AND METHOD</invention-title><invention-title mxw-id="PT132365257" lang="FR" load-source="patent-office">IMPLANT CHIRURGICAL ET PROCÉDÉ ASSOCIÉ</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR919523584" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SCIMOTANA PTY LTD</last-name><address><country>AU</country></address></addressbook></applicant><applicant mxw-id="PPAR919519424" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SCIMOTANA PTY LTD</last-name></addressbook></applicant><applicant mxw-id="PPAR919016217" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Scimotana Pty Ltd</last-name><iid>101408069</iid><address><street>Suite 1, Ground Floor 23-27 Wellington Street</street><city>St Kilda, VIC 3182</city><country>AU</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919543512" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>BATTY ANDREW</last-name><address><country>AU</country></address></addressbook></inventor><inventor mxw-id="PPAR919521625" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>BATTY, Andrew</last-name></addressbook></inventor><inventor mxw-id="PPAR919014552" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>BATTY, Andrew</last-name><address><street>Suite 1 Ground Floor 23-27 Wellington Street</street><city>St. Kilda, Victoria 3182</city><country>AU</country></address></addressbook></inventor><inventor mxw-id="PPAR919543178" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>D URSO PAUL</last-name><address><country>AU</country></address></addressbook></inventor><inventor mxw-id="PPAR919545769" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>D'URSO, PAUL</last-name></addressbook></inventor><inventor mxw-id="PPAR919012147" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>D'URSO, PAUL</last-name><address><street>Suite 1 Ground Floor 23-27 Wellington Street</street><city>St. Kilda, Victoria 3182</city><country>AU</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919005748" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Denholm, Anna Marie</last-name><iid>101273804</iid><address><street>Coller IP Management Fugro House Hithercroft Road</street><city>Wallingford, Oxon OX10 9RB</city><country>GB</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="AU-2012000199-W"><document-id><country>AU</country><doc-number>2012000199</doc-number><kind>W</kind><date>20120228</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012116401-A1"><document-id><country>WO</country><doc-number>2012116401</doc-number><kind>A1</kind><date>20120907</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549765897" load-source="docdb">AL</country><country mxw-id="DS549777602" load-source="docdb">AT</country><country mxw-id="DS549765898" load-source="docdb">BE</country><country mxw-id="DS549847293" load-source="docdb">BG</country><country mxw-id="DS549861661" load-source="docdb">CH</country><country mxw-id="DS549766245" load-source="docdb">CY</country><country mxw-id="DS549766246" load-source="docdb">CZ</country><country mxw-id="DS549845480" load-source="docdb">DE</country><country mxw-id="DS549765899" load-source="docdb">DK</country><country mxw-id="DS549765900" load-source="docdb">EE</country><country mxw-id="DS549847528" load-source="docdb">ES</country><country mxw-id="DS549847298" load-source="docdb">FI</country><country mxw-id="DS549847299" load-source="docdb">FR</country><country mxw-id="DS549845481" load-source="docdb">GB</country><country mxw-id="DS549765913" load-source="docdb">GR</country><country mxw-id="DS549845486" load-source="docdb">HR</country><country mxw-id="DS549766247" load-source="docdb">HU</country><country mxw-id="DS549861682" load-source="docdb">IE</country><country mxw-id="DS549765914" load-source="docdb">IS</country><country mxw-id="DS549847300" load-source="docdb">IT</country><country mxw-id="DS549765915" load-source="docdb">LI</country><country mxw-id="DS549845487" load-source="docdb">LT</country><country mxw-id="DS549777603" load-source="docdb">LU</country><country mxw-id="DS549845488" load-source="docdb">LV</country><country mxw-id="DS549845489" load-source="docdb">MC</country><country mxw-id="DS549777604" load-source="docdb">MK</country><country mxw-id="DS549777613" load-source="docdb">MT</country><country mxw-id="DS549847529" load-source="docdb">NL</country><country mxw-id="DS549916952" load-source="docdb">NO</country><country mxw-id="DS549847546" load-source="docdb">PL</country><country mxw-id="DS549777614" load-source="docdb">PT</country><country mxw-id="DS549847547" load-source="docdb">RO</country><country mxw-id="DS549777615" load-source="docdb">RS</country><country mxw-id="DS549847548" load-source="docdb">SE</country><country mxw-id="DS549766248" load-source="docdb">SI</country><country mxw-id="DS549916953" load-source="docdb">SK</country><country mxw-id="DS549916954" load-source="docdb">SM</country><country mxw-id="DS549847301" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA99838469" ref-ucid="WO-2012116401-A1" lang="EN" load-source="patent-office"><p num="0000">A surgical implant, which in use, provides a barrier between iayers of tissue such that tissue on one side of the implant does not adhere to tissue on the other side, the improvement comprising that the implant is made of suitably anatomically shaped surgically acceptable sheet material.</p></abstract><abstract mxw-id="PA100334054" ref-ucid="WO-2012116401-A1" lang="EN" source="national office" load-source="docdb"><p>A surgical implant, which in use, provides a barrier between iayers of tissue such that tissue on one side of the implant does not adhere to tissue on the other side, the improvement comprising that the implant is made of suitably anatomically shaped surgically acceptable sheet material.</p></abstract><abstract mxw-id="PA99838470" ref-ucid="WO-2012116401-A1" lang="FR" load-source="patent-office"><p num="0000">L'invention concerne un implant chirurgical, qui, lors de l'utilisation, fournit une barrière entre des couches de tissu, de telle sorte que le tissu se trouvant sur un côté de l'implant n'adhère pas au tissu de l'autre côté, le perfectionnement consistant en ce que l'implant est fait d'un matériau en feuille de forme anatomique appropriée, acceptable du point de vue chirurgical.</p></abstract><abstract mxw-id="PA100334055" ref-ucid="WO-2012116401-A1" lang="FR" source="national office" load-source="docdb"><p>L'invention concerne un implant chirurgical, qui, lors de l'utilisation, fournit une barrière entre des couches de tissu, de telle sorte que le tissu se trouvant sur un côté de l'implant n'adhère pas au tissu de l'autre côté, le perfectionnement consistant en ce que l'implant est fait d'un matériau en feuille de forme anatomique appropriée, acceptable du point de vue chirurgical.</p></abstract><description mxw-id="PDES51233871" ref-ucid="WO-2012116401-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="2"/>--><p id="p0001" num="0001"> Title: Surgical Implant and Method </p><p id="p0002" num="0002">Field of Invention </p><p id="p0003" num="0003"> The invention relates to the field of surgery and the provision of implants, particularly in neurosurgery. </p><p id="p0004" num="0004"> Background </p><p id="p0005" num="0005"> In response to various injuries and conditions surgeons often find it necessary to separate or remove tissue from a patient. In some procedures it is desirable that tissue does not grow onto or adhere to other tissue during healing. </p><p id="p0006" num="0006"> Decompressive craniectomy is an example of such a case. This is a neurosurgical procedure in which part of the skull is removed to allow a swelling brain room to expand. It is performed on patients that have incurred a traumatic brain injury (TBI) such as following a car accident or a fall or in patients that have suffered a stroke. </p><p id="p0007" num="0007">When a neurosurgeon performs a decompressive craniectomy, part of the skull is removed and either a) stored in the patient's abdomen b) stored in a bone fridge or c) discarded. </p><p id="p0008" num="0008"> Typically for a TBI, a 10-13cm round piece of bone is removed. The surgeon will cut along the hair line through the skin down to the bone and peel the 'skin flap' back. The surgeon will then remove bone (craniectomy) and not disturb the underlying layer of tissue, known as the dura mater. </p><p id="p0009" num="0009"> The dura mater or dura is the outermost of the three layers of the meninges surrounding the brain and spinal cord. The other two meningeal layers are the pia mater and the arachnoid mater. The dura surrounds the brain and the spinal cord and is responsible for keeping in the cerebrospinal fluid. The bone is removed and the skin and periosteum (membrane covering the bone) is sutured back up and the patient is generally sedated in ICU to allow the brain to swell. A patient can then leave the hospital and function mindful of the area in their brain unprotected by bone. </p><p id="p0010" num="0010">The patient can return for surgery to restore the cranial vault in 6 weeks to 2 years. During this time, the dura will adhere and scar to the subcutaneous tissue. To repair the cranium, the surgeon needs to re-open the same wound, and carefully separate the dura from the skin and subcutaneous tissue because the bone or implant is usually placed between these layers. This generally takes 45- 60 minutes and can cause the dura to be nicked or torn. 
<!-- EPO <DP n="3"/>-->
 While some surgeons improvise by using plastic bags and other ad hoc measures to minimize tissue adhesion, there are some basic flat silicone sheets, such as those by Bentec Medical, on the market which may be used. </p><p id="p0011" num="0011">Seprafilm® Adhesion Barrier (membrane) is an example of a basic flat sheet. This product is a sterile, bioresorbable, translucent adhesion barrier. Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.</p><p id="p0012" num="0012">Perthese ® by Mentor is yet another example of silicone sheeting that is flexible. This is a translucent silicone elastomer sheeting material designed for medical and laboratory applications. It is made from an enhanced tear resistant elastomer that consists of dimethyl and methyl vinyl siloxane copolymers which are available as non-reinforced, reinforced and non reinforced extra firm varieties. </p><p id="p0013" num="0013">GORE PRECLUDE® PDX Dura Substitute is also available. This product is a flat sheet of opaque white material composed of PTFE (polytetrafluoroethylene) and is indicated for use as a temporary or permanent prosthesis for repair of dura mater during neurosurgery. GORE PRECLUDE® PDX Dura Substitute is for staged procedures and those that may require re-operation, such as, decompressive craniectomies, brain electrode mapping for seizure disorders, recurrent brain and spinal tumors. </p><p id="p0014" num="0014"> The above references to and descriptions of prior proposals or products are not intended to be, and are not to be construed as, statements or admissions of common general knowledge in the art. </p><p id="p0015" num="0015"> Summary </p><p id="p0016" num="0016"> In one aspect the present invention provides a surgical implant, which in use, provides a barrier between layers of tissue such that tissue on one side of the implant does not adhere to tissue on the other side, the improvement comprising that the implant is made of suitably anatomically shaped surgically acceptable sheet material. </p><p id="p0017" num="0017"> The surgical implant may be for temporary or permanent use. Preferably the implant is for temporary use. </p><p id="p0018" num="0018"> The term "suitably anatomically shaped" refers to a shape which suits the anatomy of the body where the implant is to be used. Preferably the material is curved. Even more preferably the material is shaped to conform to a region of the human cranium. More preferably the material is shaped to conform to the temporo-parietal or frontal lobe of the cranium. Preferably the pre-contoured 
<!-- EPO <DP n="4"/>-->
 material is suitable for left and right sides of the frontal lobe (bi-frontal) or suitable for the temporo-parietal lobe. Conveniently the pre-contoured material for the left or right side of the frontal lobe is adjustable for the left or right side by inverting the material from one side to the other. More preferably the surgical implant is oversized enabling the surgeon to trim it to suit the required size of the cranial defect. </p><p id="p0019" num="0019"> The term "surgically acceptable sheet material" refers to implant material that is biologically inert relatively thin material such as sheet material in the form of silicone, polytetrafluoroethylene or other materials with the desirable properties. The sheet material may include a matrix, mesh, gauze and the like. The sheet material may also be transparent or opaque. The material may be biodegradable and/or resorbable. </p><p id="p0020" num="0020">Preferably the sheet material is thin and flexible. More preferably the sheet material is around 0.5mm thick and is made of pre-shaped medical grade silicone film. It is preferred particularly that the sheet material is less than 0.5mm thick.</p><p id="p0021" num="0021">Optionally the sheet material is reinforced in certain areas to assist in suture retention; the reinforcement including increasing the material thickness or adding a second, more resilient material, such as woven polyester. Additionally the surgical implant may contain fixation sites, such as perforations, with or without reinforcement, that allow sutures screws or rivets to be used to secure the implant to the surrounding hard or soft tissues. Preferably the sheet material includes one or more areas of reinforcement adapted to prevent sutures from pulling out or cutting through the sheet. </p><p id="p0022" num="0022"> Optionally the sheet material may have other useful properties. For example the sheet material may incorporate one or more pharmaceutical compositions, such as antibiotics and anti inflammatory compounds. Such agents may be introduced via material porosity or via the incorporation of a second material with such porosity that may or may not be biodegradable at a predetermined rate. </p><p id="p0023" num="0023"> In a preferred form, the present invention is pre-shaped/contoured to allow the implant to conform to the anatomy of the cranium. Other advantages include that the implant is thin and flexible and or elastic, allowing the brain to continue to swell after initial surgery. Further, the implant is modifiable which means that it can be trimmed intra-operatively. The implant may be permanent so that it will not resorb or be semi-permanent or slowly resorbable so re-implantation of the bone or another implant can be carried out at the best time to promote patient recovery. </p><p id="p0024" num="0024"> In another aspect the invention relates to a surgical method of providing a barrier between layers of tissue by use of an implant such that tissue on one side of the implant does not adhere to tissue on the other side, the improvement comprising 
<!-- EPO <DP n="5"/>-->
 appropriately inserting into a patient the implant wherein the implant is made of suitably anatomically shaped surgically acceptable sheet material. </p><p id="p0025" num="0025"> Preferably the implant used is that according to the first aspect of the invention in a decompressive craniectomy or when a second stage cranioplastic procedure is likely to be necessary </p><p id="p0026" num="0026"> In another aspect, the invention provides an implant made of suitably anatomically shaped surgically acceptable biocompatible sheet material incorporating monitoring probes. Such probes may be incorporated into the invention at the time of manufacture or be attached to specially designed fixtures that allow such probes to be held in position such that they may be secured in direct contact with the underlying brain or associated structures by way of apertures within the implant. Such probes may have one or numerous monitoring functions such as intracranial pressure, temperature, electroencephalometric, blood gas saturation, pH, and microdialysis for biochemical monitoring. </p><p id="p0027" num="0027"> In yet another aspect, the invention provides an implant made of suitably anatomically shaped surgically acceptable sheet material incorporating therapeutic delivery mechanisms or substances. Such mechanisms or substances may be incorporated into the implant at the time of manufacture by direct binding via porosity of the material or be bound to an incorporated delivery material. Alternatively, the mechanisms or substances may be attached to specially designed fixtures that allow such probes to be held in position such that they may be secured in direct contact with the underlying brain or associated structures by way of apertures within the implant. Such a mechanism may incorporate enclosed channels within the implant to deliver therapeutic substances to the brain and associated tissues via apertures or probes. Such substances may include antibiotic, anticonvulsant, stem cells or drugs that limit secondary neuronal damage. Such a mechanism may include slow release biodegradable substances that release therapeutic agents in a predictable time released way. </p><p id="p0028" num="0028">Another aspect of the invention relates to the provision of an implant made of suitably anatomically shaped surgically acceptable sheet material with an enclosed system of channels that allow the circulation of fluid to and from an external device incorporating a positive or negative pressure hydraulic pump. For example such a system could allow the circulation of fluid to modify the temperature of the brain. Such a system could induce regional hypothermia of the brain. </p><p id="p0029" num="0029"> Yet another aspect of the invention relates to the provision of an implant made of suitably anatomically shaped surgically acceptable sheet material with a network of channels that allow the closed circulation of fluid to and from an external device incorporating a positive or negative pressure hydraulic pump. A semi- 
<!-- EPO <DP n="6"/>-->
 permeable membrane may be used between such channels and the surface of the brain. The membrane may be designed so that only substances with specific molecular weights may cross. This would allow osmotic forces to be harnessed and allow substance or fluids to cross selectively to or from the brain for therapeutic purposes. </p><p id="p0030" num="0030"> Still another aspect of the invention relates to the provision of an implant made of suitably anatomically shaped surgically acceptable sheet material with porosity or a scaffold and a network of channels to and from an incorporated port or reservoir. Such a port could be accessed percutaneously via injection or through access apertures so that therapeutic substances and stem cells could be introduced to promote the formation of new bone to integrate the invention with the surrounding skull. </p><p id="p0031" num="0031">Although described primarily in relation to the human cranium, the implant of the present invention may be suitably shaped and fabricated so that it may be used elsewhere in the body including but not limited to the treatment of conditions of the chest, abdomen, pelvis and limbs. </p><p id="p0032" num="0032">Brief Description of the Figures </p><p id="p0033" num="0033"> Figure 1 is a representation of implants suitable for procedures on the temporoparietal and the frontal lobe of a human cranium. </p><p id="p0034" num="0034"> Detailed Description of Illustrative Embodiment of the Invention </p><p id="p0035" num="0035">The invention will now be described with reference to the following non limiting illustration. </p><p id="p0036" num="0036"> Figure 1 shows the implant of the invention suitable for temporo-parietal and frontal lobe use on a skull. The surgeon uses standard surgical techniques to fit the implant however it should be noted that compared to using a flat sheet the pre-shaped and contoured implant of the present invention is simpler to fit, saves operating theatre time and minimizes discomfort as a flat sheet may buckle or overlap. Further, the curved nature of the implant of the present invention means that it is more likely to remain in place in the defect. A flat sheet may buckle or overlap and cause discomfort and make a second procedure necessary. </p><p id="p0037" num="0037"> Throughout this specification and the claims that follow, unless the context requires otherwise the words "comprise", "comprises", "comprising" will be understood to mean the inclusion of the stated integer, step or group of integers or steps but not the exclusion of any of other integer, step or group of integers or steps. 
</p></description><claims mxw-id="PCLM44853055" ref-ucid="WO-2012116401-A1" lang="EN" load-source="patent-office"><claim id="clm-0001" num="1"><!-- EPO <DP n="7"/>--><claim-text> The claims defining the invention are as follows: 1. A surgical implant, which in use, provides a barrier between layers of tissue such that tissue on one side of the implant does not adhere to tissue on the other side, the improvement comprising that the implant is made of suitably anatomically shaped surgically acceptable sheet material. </claim-text></claim><claim id="clm-0002" num="2"><claim-text>2. The implant of claim 1 shaped to conform to the human cranium. </claim-text></claim><claim id="clm-0003" num="3"><claim-text> 3. The implant of claim 2 shaped to conform to the frontal or temporo-parietal regions of the cranium. </claim-text></claim><claim id="clm-0004" num="4"><claim-text>4. The implant of any one of claims 1 to 3 which comprises medical grade flexible silicone film. </claim-text></claim><claim id="clm-0005" num="5"><claim-text> 5. The implant of any previous claim in which the sheet material is reinforced in certain areas for suture retention or the sheet material contains fixation sites that allow sutures screws or rivets to be used to secure the implant to the surrounding hard or soft tissues. </claim-text></claim><claim id="clm-0006" num="6"><claim-text> 6. The implant of any previous claim in which the sheet material incorporates one or more pharmaceutical compositions, such as antibiotics and anti inflammatory compounds. </claim-text></claim><claim id="clm-0007" num="7"><claim-text> 7, The implant of any previous claim in which the sheet material incorporates monitoring probes. </claim-text></claim><claim id="clm-0008" num="8"><claim-text>8. The implant of claim 8 in which the probes have one or numerous monitoring functions, such as intracranial pressure, temperature, electroencephalometric, blood gas saturation, pH and microdialysis for biochemical monitoring. </claim-text></claim><claim id="clm-0009" num="9"><claim-text> 9. The implant of any previous claim in which the sheet material incorporates therapeutic delivery mechanisms or substances. </claim-text></claim><claim id="clm-0010" num="10"><claim-text> 10. The implant of claim 9 comprising enclosed channels within the implant to deliver therapeutic substances to the brain and associated tissues via apertures or probes. </claim-text></claim><claim id="clm-0011" num="11"><claim-text> 11. The implant of any previous claim in which the sheet material comprises a closed system of channels that allow the circulation of fluid to and from an external device incorporating a positive or negative pressure pump. <!-- EPO <DP n="8"/>--> </claim-text></claim><claim id="clm-0012" num="12"><claim-text>12. The implant of any one of claims 1 to 10 comprising a network of channels that allow the closed circulation of fluid to and from an external device incorporating a positive or negative pressure pump. </claim-text></claim><claim id="clm-0013" num="13"><claim-text>13. The implant of claim 12 comprising a semi-permeable membrane between the channels and the surface of the brain. </claim-text></claim><claim id="clm-0014" num="14"><claim-text> 14 The implant of claim 13 in which the membrane is designed so that only substances with specific molecular weights may cross. </claim-text></claim><claim id="clm-0015" num="15"><claim-text> 15 The implant of any previous claim in which the sheet material comprises a scaffold and a network of channels to and from an incorporated port or reservoir.</claim-text></claim><claim id="clm-0016" num="16"><claim-text>16. The implant of claim 15 in which a port is accessed percutaneously via injection or through access apertures so that therapeutic substances and stem cells can be introduced to promote the formation of new bone to integrate the implant with the surrounding skull. </claim-text></claim><claim id="clm-0017" num="17"><claim-text> 17. A surgical method of providing a barrier between layers of tissue by use of an implant such that tissue on one side of the implant does not adhere to tissue on the other side, the improvement comprising appropriately inserting the implant in a patient wherein the implant is made of suitably anatomically shaped surgically acceptable sheet material. </claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
